Overview
Elligo Labs is a company that streamlines clinical trials by providing integrated care, patient recruitment, and retention services. They connect studies to a network of research-ready sites, enabling faster patient access and higher retention rates. Additionally, they offer decentralized clinical trial solutions that adapt to specific study needs, enhancing operational efficiency.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dariusz Piotr Graczyk (53) | 60 | $1,620.75 | 60% |
Ewelina Anna Smolińska (43) | 40 | $1,080.50 | 40% |
Beneficial owners
| Person | Rights |
|---|---|
Dariusz Piotr Graczyk (53)  | Shareholder of a limited liability company, 6000.0 PLN |
Ewelina Anna Smolińska (43) | Shareholder of a limited liability company, 4000.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Bio-Labsp. z o.o. | $320,999.14 | bio-lab.com.pl | |
| Medical Smart Integratorsp. z o.o. | $317,541.89 | medicalsmartintegrator.pl | |
| Pergamonmedsp. z o.o. | $296,205.09 | pergamonmed.pl | |
| Espensp. z o.o. | $56,231.79 | diather.pl |
FAQ
Last updated: 2026-07-15